Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Enrolling by invitation 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Breast Neoplasms 1225Neoplasms 1042Carcinoma, Non-Small-Cell Lung 751Prostatic Neoplasms 689Colorectal Neoplasms 591Lung Neoplasms 574Pancreatic Neoplasms 404Leukemia, Myeloid, Acute 396Neoplasm Metastasis 386Multiple Myeloma 372Ovarian Neoplasms 371Stomach Neoplasms 319Carcinoma, Hepatocellular 301Recurrence 281Melanoma 280Brain Neoplasms 280Squamous Cell Carcinoma of Head and Neck 268Head and Neck Neoplasms 235Glioblastoma 233Endometrial Neoplasms 232Triple Negative Breast Neoplasms 229Precursor Cell Lymphoblastic Leukemia-Lymphoma 228Lymphoma 225Uterine Cervical Neoplasms 223Sarcoma 200Hematologic Neoplasms 199Urinary Bladder Neoplasms 197Esophageal Neoplasms 193Carcinoma, Renal Cell 189Lymphoma, Non-Hodgkin 176

Interventions

Specimen Handling 1Psilocybin 1Interviews as Topic 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Depressive Disorder × 1 year × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

NCT07290153 2025-12-18

SCHBCC-N0105

Fudan University

Recruiting
120 enrolled
Breast

Generalized Anxiety Disorder, Breast Neoplasms, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡